Simonds R J, Lindegren M L, Thomas P, Hanson D, Caldwell B, Scott G, Rogers M
Division of HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, GA 30333.
N Engl J Med. 1995 Mar 23;332(12):786-90. doi: 10.1056/NEJM199503233321206.
Pneumocystis carinii pneumonia (PCP) remains a common and often fatal opportunistic infection among children infected with the human immunodeficiency virus (HIV). HIV-infected infants between three and six months of age are particularly vulnerable. Current guidelines recommend prophylaxis in children from birth to 11 months old who have CD4+ counts below 1500 cells per cubic millimeter.
We used national surveillance data to estimate the annual incidence of PCP among children less than one year old. We reviewed the medical records of 300 children given a diagnosis of PCP between January 1991 and June 1993 to determine why treatment according to the 1991 guidelines for prophylaxis against PCP either was not given or failed to prevent the disease.
In our study the incidence of PCP in the first year of life among infants born to HIV-infected mothers changed little between 1989 and 1992. Among 7080 children born to HIV-infected mothers in 1992, PCP developed in 2.4 percent. Of 300 children with PCP diagnosed from January 1991 through June 1993, 199 (66 percent) had never received prophylaxis, and for 118 of those children (59 percent) exposure to HIV was first identified 30 days or less before the diagnosis of PCP. Among 129 children less than one year old, the CD4+ count declined by an estimated 967 cells per cubic millimeter (95 percent confidence interval, 724 to 1210 cells per cubic millimeter) during the three months before the diagnosis of PCP. Among infants in whom CD4+ counts were determined within one month of the diagnosis of PCP, 18 percent (20 of 113) had at least 1500 cells per cubic millimeter, a level higher than the currently recommended threshold for prophylaxis.
In the United States the incidence of PCP among HIV-infected infants has not declined. If this infection is to be prevented, infants exposed to HIV must be identified earlier, and prophylaxis must be offered to more children than the guidelines currently recommend.
卡氏肺孢子虫肺炎(PCP)在感染人类免疫缺陷病毒(HIV)的儿童中仍然是一种常见且往往致命的机会性感染。3至6个月大的HIV感染婴儿尤其易受感染。当前指南建议,对出生至11个月大、CD4+细胞计数低于每立方毫米1500个的儿童进行预防。
我们利用国家监测数据估算1岁以下儿童中PCP的年发病率。我们查阅了1991年1月至1993年6月期间被诊断为PCP的300名儿童的病历,以确定为何未按照1991年PCP预防指南进行治疗或治疗未能预防该病。
在我们的研究中,1989年至1992年间,HIV感染母亲所生婴儿在出生后第一年的PCP发病率变化不大。1992年,在7080名HIV感染母亲所生儿童中,2.4%发生了PCP。在1991年1月至1993年6月被诊断为PCP的300名儿童中,199名(66%)从未接受过预防,其中118名儿童(59%)在PCP诊断前30天或更短时间首次被发现感染HIV。在129名1岁以下儿童中,PCP诊断前三个月期间,CD4+细胞计数估计每立方毫米下降967个(95%置信区间为每立方毫米724至1210个)。在PCP诊断后1个月内测定CD4+细胞计数的婴儿中,18%(113名中的20名)每立方毫米至少有1500个细胞,这一水平高于目前推荐的预防阈值。
在美国,HIV感染婴儿中PCP的发病率并未下降。若要预防这种感染,必须更早识别感染HIV的婴儿,并且对更多儿童提供预防,超出目前指南的建议范围。